MENU
ACST
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Acasti Pharma (ACST) Ownership - Who owns Acasti Pharma?

Profile

Industry
Pharmaceuticals Other
Address
3009 Boulevard de la Concorde East
Phone
+1 450 686-4555
Employees
7
Web
https://www.acastipharma.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
31.64M
P/E Ratio
N/A
Total Cash
27.88M
Projected Growth
N/A
Total Debt
N/A
Revenue
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
2.75
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price

Fundamentals

ACST
Capitalization
31.6M
P/E Ratio
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
27.9M
Total Cash/Share
2.75
Total Debt
0
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
N/A
ROE
N/A
Book Value
61.7M
P/B Ratio
0.53
Cash Flow
N/A
Earnings
N/A
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
261M
Current Ratio
14.26
Current Revenue Per Employee
3593.75
Dividends Per Share - Security
N/A
EBITDA
N/A
Float
N/A
Float - Current
N/A
Gross Income Margin
65.22
Revenue To Assets
N/A
Shares Held By Institutions
N/A
Shares Outstanding - Current
10.1M
Total Liabilities
11.6M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-11.592
View a ticker or compare two or three
ACST
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a manufacturer of Pharmaceutical products

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
3009 Boulevard de la Concorde East
Phone
+1 450 686-4555
Employees
7
Web
https://www.acastipharma.com